Cite
HARVARD Citation
Guiotto, C. et al. (2016). Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease. Digestive and liver disease. 48 (2), pp. 138-143. [Online].